The United States could safely reduce the frequency of tetanus and diphtheria booster shots for adults and save an estimated $1 billion per year, according to a new review led by researchers at Oregon Health & Science University.
This conclusion depends on the U.S. maintaining very high childhood vaccination rates.
Vaccines for tetanus and diphtheria are referred to as “legacy” vaccines by the healthcare industry because they were developed in the 1920s, during a time when the U.S. Food and Drug Administration was in its early stages of development.
Ending Tetanus, Diphtheria Booster for Adults Could Save $1 Billion
Chikungunya Infection May Lead to Long-Term Joint Pain
The Chikungunya virus, transmitted by mosquitoes, has emerged as a significant global health concern. Recent outbreaks have spread beyond their usual regions in Africa and Asia to areas such as the Region of the Americas, China, France, and India.
Although the acute febrile illness typically resolves within a few days, many patients experience prolonged joint pain and arthritis.
This can severely impact their quality of life and place a burden on healthcare resources.